Fiacitabine

非西他滨

Report date: 2022/12/07 18:09:52
NME

Base Information

Drug NameFiacitabine
Drug Alias NameFOACFIAC
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionHuman herpesvirus 1 DNA polymerase inhibitorsHuman herpesvirus 5 DNA polymerase inhibitors
TargetsHuman herpesvirus 5 DNA polymeraseHuman herpesvirus 1 DNA polymerase
Therapy Area/IndicationsCytomegalovirus InfectionsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsCytomegalovirus InfectionsHIV Infections

Other Information

ATC CodeN/A
Related LinksKEGG